Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
You can find previous posts in the Employer Coverage archive Please subscribe, like share this newsletter with friends and colleagues
doi: 10.18632/oncotarget.2034 191 DasSShuklaNSinghSSKushwahaSShrivastavaRJA
T ransient nausea, diarrhea, and mild irritation at the injection site have been reported as adverse undesirable effects in preclinical studies
Creatine kinase and lactate dehydrogenase, markers of muscle damage, decrease after repeated cryotherapy sessions
Berk M, Copolov D, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Judd F, Katz F, Katz P, Ording-Jespersen S, Little J, Conus P, Cuenod M, Do KQ, Busha AI: N-acetyl cysteine as a glutathione precursor for schizophreniaa double-blind, randomized, placebo-controlled trial
In the realm of cell-based therapies and antibodydrug conjugates (ADCs), CT041, a CLDN18.2-targeted CAR-T product, is being studied in gastrointestinal cancers (NCT04404595), while enfortumab vedotin, targeting Nectin-4, is under investigation for metastatic castration-resistant prostate cancer (NCT04754191)
US$ 28.90
US$ 29.80
US$ 22.54
US$ 20.48
US$ 27.65
US$ 25.84
